TwitterLinkedInFacebook Instagram
United StatesLanguage Flag

Press Release

OraSure Technologies Invites You To Join Its 2003 Fourth Quarter and Full-Year Financial Results Conference Call

January 28, 2004 at 6:01 AM EST

BETHLEHEM, Penn.--(BUSINESS WIRE)--Jan. 28, 2004--OraSure Technologies, Inc. (Nasdaq NM:OSUR) will host a conference call with analysts and an audio webcast to discuss the Company's 2003 fourth quarter and full-year financial results, and 2004 guidance and major business objectives, beginning at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on Tuesday, February 10, 2004. The call will be preceded by the release of the Company's 2003 financial results, which will occur immediately after the market closes that day.

In order to listen to the conference call, please either dial 888-742-2024 (Domestic) or 706-643-0033 (International) or go to OraSure Technologies' web site, www.orasure.com, and click on the Investor Info link at the top of the page. A replay of the call will be archived on OraSure Technologies' web site shortly after the call has ended and will be available for seven days. A replay of the call can also be accessed until February 13, 2004, by dialing 800-642-1687 (Domestic) or 706-645-9291 (International) and entering the Conference ID #4884253.

The webcast will also be distributed over the CCBN (Corporate Communications Broadcast Network) Investor Distribution Network. Institutional investors can access the call via CCBN's password protected event management site, StreetEvents (www.streetevents.com).

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. OraSure is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV-1. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com.


    CONTACT: OraSure Technologies
             Ronald H. Spair, 610-882-1820
             Investorinfo@orasure.com
             www.orasure.com

    SOURCE: OraSure Technologies
© OraSure Technologies., 2024